The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I see it down 3 cents on 1,100 share volume....where are you seeing up 6%?
Whim...ah good point...too much going on here to keep track..
Still...23 days...sloppy
Also took 23 days to notify the company....
Starknight....This going to shoot up? An entity the Executive Chairman has a beneficial interest in just reduced their holdings by 8.3m shares by my reckoning.
The trading volume on both AIM and NDQ for 5th August doesn't seem to cover this disposal. Off market transfer to another entity?
Curious.
Two companies discussed here announce tie up via non binding LOI
https://financialpost.com/pmn/business-pmn/veoneer-announces-tie-up-with-qualcomm-shares-jump-15
CW25...agree this is a science based investment for me.
I have to live with the 24 hour election news cycle and all the Trump headlines in US so it permeating this board is something I could do without and not particularly relevant to the long term success of Synairgen imo.
I think the Eurobond they are referring to is due April 2021 not 2020. The bonds seem to be trading expecting that refinancing should proceed.
This maybe also a reason for the company to retain the recent cash from the Polish tax judgement rather than pay out. The refinancing could also influence restatement of a dividend.
Company seems to have made good progress since virus hit.
SpotCo filed litigation in NY State Supreme Court suing Scott Rudin claiming he owed the company $6.3M for work done on 8 shows he was producing prior to Broadway shutdown.
Company apparently also confirmed that they provided services without a written contract. Hard to believe but that is what is being reported.
Yeah no way to tell if they keep buying.
Possible if they are picking up what they perceive as cheap shares with Landsdowne selling down providing liquidity, then they may continue buying.
On the flip side new positions they open seem to run in the $15M to $30M range. They are already at $21M ish with 5.09%. Portfolio management and sizing will play a role as well.
Interesting couple of weeks ahead undoubtedly.
Wilts...totally agree that VHCP is far better partner than Landsdowne.
From my experience of early stage VC they typically look for a 10X return on investments....8 losers and 2 winners and they are still ahead of the game. This 10X is normally for private investments and suspect the desired return profile for early stage public investments is less given the relative de-risking of early stage public versus late stage private companies.
Sparkle1.. VHCP are an early stage investor (venture) as opposed to private equity (late stage). I would be surprised if their strategy is to take private, rather they look for later stage private investments to take public or early stage public investments.
Premarket
Just anoint.....$6 (prematurity) and £2.30
If we are to believe that the raise has been placed with two investors...read this on the board but haven't seen official confirmation...then should be expect new TR1's later in the week?
Will be interested to see and also what the new shareholders do. Hopefully stick around.
Mr Singh...I am glad I could bring some levity to your day as the all caps posts could be a sign of a stressful day. Just speculating.
I am building a core position here and taking advantage of any weakness. If I was in this for a trade then would have traded the $12 spike Friday....as you did. Congratulations.
Sit back and enjoy your profits.